Table 1.

Patient Characteristics and Health Status

CohortsPrimaryCrossoverCombinedTotal N
SMTOATSMTXOATXSMTCOATC

N4,99820,9471,4317846,42921,73128,160
Age at cohort accrual (years) Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD -
73.14.872.64.873.14.972.94.773.14.872.64.8-

Age Category (years) n % N % n % n % n % n % -
65–691,59932.0%7,81737.3%46132.2%25432.4%2,06032.0%8,07137.1%10,131
70–741,72134.4%6,78732.4%49534.6%28336.1%2,21634.5%7,07032.5%9,286
75–791,12522.5%4,25420.3%30221.1%17221.9%1,42722.2%4,42620.4%5,853
80–8455311.1%2,08910.0%17312.1%759.6%72611.3%2,16410.0%2,890

Sex
Male1,44028.8%5,54326.5%35524.8%19124.4%1,79527.9%5,73426.4%7,529
Female3,55871.2%15,40473.5%1,07675.2%59375.6%4,63472.1%15,99773.6%20,631

Race/Ethnicity
White4,76895.4%17,58684.0%1,35995.0%74194.5%6,12795.3%18,32784.3%24,454
Other / Unknown2304.6%3,36116.1%725.0%435.5%3024.7%3,40415.7%3,706

Socioeconomic Status
Low income subsidy4979.9%10,29149.1%33023.1%10613.5%82712.9%10,39747.8%11,224
Dual eligibility4148.3%8,88242.4%26518.5%8911.4%67910.6%8,97141.3%9,650

Charlson Comorbidity Score
03,19563.9%8,74041.7%72350.5%44456.6%3,91860.9%9,18442.3%13,102
11,14622.9%6,14829.4%40828.5%19524.9%1,55424.2%6,34329.2%7,897
24458.9%3,41216.3%17712.4%9311.9%6229.7%3,50516.1%4,127
31483.0%1,4997.2%795.5%334.2%2273.5%1,5327.0%1,759
4+641.3%1,1485.5%443.1%192.4%1081.7%1,1675.4%1,275

Chronic Condition
Osteoarthritis of the Hip1222.4%1,3096.3%1017.1%354.5%2233.5%1,3446.2%1,567
Osteoarthritis of the Knee4599.2%3,42716.4%27319.1%12415.8%73211.4%3,55116.3%4,283
Fibromyalgia1,40228.1%6,01528.7%60242.1%25832.9%2,00431.2%6,27328.9%8,277
Depressive Disorder4128.2%6,14629.3%31121.7%12215.6%72311.2%6,26828.8%6,991

LBP Diagnosis Category
Non-Specific LBP4,83396.7%15,64674.7%1,30190.9%73093.1%6,13495.4%16,37675.4%22,510
Radiculopathy1132.3%3,27215.6%795.5%354.5%1923.0%3,30715.2%3,499
Herniated Disc * * 440.2% * * * * * * 440.2%44
Spondylolisthesis * * 2741.3% * * * * 110.2%2761.3%274
Sprain/Strain240.5%1250.6% * * * * 300.5%1300.6%149
Spinal Stenosis230.5%1,5867.6%362.5%121.5%590.9%1,5987.4%1,657

Notes: Cohort Definitions: SMT = subjects who initiated SMT in 2013 for long-term management of cLBP, with no concurrent OAT; OAT = subjects who initiated OAT in 2013 for long-term management of cLBP, with no concurrent SMT; SMTX = subjects with any occurrence of SMT in 2013, followed by initiation in 2013 of OAT for long-term management of cLBP; OATX = subjects with any occurrence of OAT in 2013, followed by initiation in 2013 of SMT for long-term management of cLBP; SMTC = combination of SMT and SMTX; OATC = combination of OAT and OATX; n = number of subjects; n/a = not applicable;

*= data suppressed in accordance with CMS rules